Traynor Capital Management, Inc. Johnson & Johnson Transaction History

Traynor Capital Management, Inc.

$1.6 Billion
Q3 2024

A detailed history of Traynor Capital Management, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Traynor Capital Management, Inc. holds 4,442 shares of JNJ stock, worth $688,687. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,442

Previous 4,661 4.7%

Holding current value

$688,687

Previous $681,000 5.58%

% of portfolio

0.04%

Previous 0.05%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$145.48 - $167.38 $31,860 - $36,656	-219 Reduced 4.7%	4,442 $719,000
Q2 2024 Jul 24, 2024	SELL	$144.38 - $157.78 $922,732 - $1.01 Million	-6,391 Reduced 57.83%	4,661 $681,000
Q1 2024 Apr 12, 2024	SELL	$155.22 - $162.74 $155,840 - $163,390	-1,004 Reduced 8.33%	11,052 $1.75 Million
Q4 2023 Jan 18, 2024	SELL	$145.6 - $158.88 $38,292 - $41,785	-263 Reduced 2.13%	12,056 $1.89 Million
Q3 2023 Oct 16, 2023	SELL	$155.75 - $174.48 $119,460 - $133,826	-767 Reduced 5.86%	12,319 $1.92 Million
Q2 2023 Jul 28, 2023	SELL	$154.35 - $166.11 $530,192 - $570,587	-3,435 Reduced 20.79%	13,086 $2.17 Million
Q1 2023 Apr 21, 2023	SELL	$151.05 - $180.26 $617,945 - $737,443	-4,091 Reduced 19.85%	16,521 $2.56 Million
Q4 2022 Jan 27, 2023	SELL	$160.2 - $179.79 $1.02 Million - $1.14 Million	-6,350 Reduced 23.55%	20,612 $0
Q3 2022 Nov 15, 2022	BUY	$161.33 - $179.52 $967,173 - $1.08 Million	5,995 Added 28.59%	26,962 $4.4 Million
Q3 2022 Oct 20, 2022	SELL	$161.33 - $179.52 $1.05 Million - $1.17 Million	-6,531 Reduced 23.75%	20,967 $3.43 Million
Q2 2022 Jul 28, 2022	SELL	$168.19 - $186.01 $493,133 - $545,381	-2,932 Reduced 9.64%	27,498 $4.88 Million
Q1 2022 Apr 13, 2022	SELL	$158.14 - $179.59 $141,060 - $160,194	-892 Reduced 2.85%	30,430 $5.39 Million
Q4 2021 Feb 01, 2022	SELL	$155.93 - $173.01 $127,238 - $141,176	-816 Reduced 2.54%	31,322 $5.36 Million
Q3 2021 Oct 25, 2021	BUY	$161.5 - $179.47 $146,157 - $162,420	905 Added 2.9%	32,138 $5.19 Million
Q2 2021 Jul 21, 2021	BUY	$159.48 - $171.07 $227,418 - $243,945	1,426 Added 4.78%	31,233 $5.28 Million
Q1 2021 May 04, 2021	BUY	$153.07 - $170.48 $534,673 - $595,486	3,493 Added 13.27%	29,807 $4.9 Million
Q4 2020 Jan 14, 2021	SELL	$137.11 - $157.38 $41,133 - $47,214	-300 Reduced 1.13%	26,314 $4.14 Million
Q3 2020 Oct 26, 2020	BUY	$140.38 - $153.83 $181,932 - $199,363	1,296 Added 5.12%	26,614 $3.87 Million
Q2 2020 Aug 10, 2020	BUY	$128.81 - $155.51 $664,273 - $801,965	5,157 Added 25.58%	25,318 $3.56 Million
Q1 2020 Apr 29, 2020	BUY	$111.14 - $153.99 $44,233 - $61,288	398 Added 2.01%	20,161 $2.64 Million
Q4 2019 Jan 24, 2020	BUY	$127.5 - $146.44 $122,400 - $140,582	960 Added 5.11%	19,763 $2.88 Million
Q3 2019 Nov 01, 2019	BUY	$126.95 - $142.14 $133,043 - $148,962	1,048 Added 5.9%	18,803 $2.43 Million
Q2 2019 Jul 26, 2019	SELL	$131.15 - $144.24 $248,660 - $273,479	-1,896 Reduced 9.65%	17,755 $2.47 Million
Q1 2019 Apr 12, 2019	BUY	$125.72 - $139.79 $143,949 - $160,059	1,145 Added 6.19%	19,651 $2.75 Million
Q4 2018 Jan 24, 2019	BUY	$122.84 - $147.84 $159,692 - $192,192	1,300 Added 7.56%	18,506 $2.39 Million
Q3 2018 Oct 24, 2018	BUY	$121.58 - $142.88 $47,294 - $55,580	389 Added 2.31%	17,206 $2.38 Million
Q2 2018 Aug 03, 2018	BUY	$119.4 - $131.76 $225,307 - $248,631	1,887 Added 12.64%	16,817 $2.04 Million
Q1 2018 May 01, 2018	BUY	$125.1 - $148.14 $256,830 - $304,131	2,053 Added 15.94%	14,930 $1.91 Million
Q4 2017 Feb 01, 2018	BUY	$131.22 - $143.62 $269,657 - $295,139	2,055 Added 18.99%	12,877 $1.8 Million
Q3 2017 Oct 27, 2017	BUY	$129.47 - $135.38 $1.4 Million - $1.47 Million	10,822	10,822 $1.4 Million

Others Institutions Holding JNJ

# of Institutions

4,239

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Traynor Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Traynor Capital Management, Inc. with notifications on news.

Account

Traynor Capital Management, Inc. Johnson & Johnson Transaction History